Maternal benefits of immunization during pregnancy

Vaccine

Volumn 33, Issue 47, 2015, Pages 6436-6440

  Swamy, Geeta K ^a   Beigi, Richard H ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Maternal immunization; Passive immunity; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; STREPTOCOCCUS VACCINE; VACCINE;

ARTICLE; DIPHTHERIA; HEPATITIS A; HEPATITIS B; HIGH RISK POPULATION; IMMUNIZATION; INFECTION PREVENTION; INFLUENZA; MATERNAL WELFARE; MENINGOCOCCOSIS; PASSIVE IMMUNIZATION; PERTUSSIS; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; TETANUS; UNITED STATES; DISEASE TRANSMISSION; FEMALE; HUMAN; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; PROCEDURES;

DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HUMANS; IMMUNIZATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UNITED STATES; VACCINES;

EID: 84947933108     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.08.035     Document Type: Article

References (48)

1. Beigi R.H. Prevention and management of influenza in pregnancy. Obstet Gynecol Clin North Am 2014, 41(December (4)):535-546.
2. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al., et al. Effectiveness of maternal influenza immunization in mothers and infants. New Engl J Med 2008, 359(October (15)):1555-1564.
3. Englund J.A., Mbawuike I.N., Hammill H., Holleman M.C., Baxter B.D., Glezen W.P. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis 1993, 168(September (3)):647-656.
4. Centers for Disease Control and, Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women 2012, vol. 622013:131-135. Advisory Committee on Immunization Practices (ACIP).
5. RSV F vaccine maternal immunization study in healthy third-trimester pregnant women 2015, https://clinicaltrials.gov/ct2/show/NCT02247726 [accessed 10.05.15].
6. Safety and immunogenicity of a trivalent group B Streptococcus vaccine in healthy pregnant women 2015, https://clinicaltrials.gov/ct2/show/NCT02046148 [accessed 2.05.15].
7. Centers for Disease Control and Prevention Adult immunization schedules 2015, http://www.cdc.gov/vaccines/schedules/hcp/adult.html [accessed 11.05 2015].
8. Cantu J., Tita A.T. Management of influenza in pregnancy. Am J Perinatol 2013, 30(2):99-103.
9. Neuzil K.M., Reed G.W., Mitchel E.F., Simonsen L., Griffin M.R. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998, 148(December (11)):1094-1102.
10. Pierce M., Kurinczuk J.J., Spark P., Brocklehurst P., Knight M. Ukoss perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. Br Med J 2011, 342:d3214.
11. Yates L., Pierce M., Stephens S., Mill A.C., Spark P., Kurinczuk J.J., et al. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess 2010, 34:109-182.
12. American College of Obstetricians Gynecologists Committee opinion no. 608 influenza vaccination during pregnancy. Obstet Gynecol 2014, 124(3):648-651.
13. Madhi S.A., Cutland C.L., Kuwanda L., Weinberg A., Hugo A., Jones S., et al. Influenza vaccination of pregnant women and protection of their infants. New Engl J Med 2014, 371(September (10)):918-931.
14. Black S.B., Shinefield H.R., France E.K., Fireman B.H., Platt S.T., Shay D., et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol 2004, 21(August (6)):333-339.
15. Haberg S.E., Trogstad L., Gunnes N., Wilcox A.J., Gjessing H.K., Samuelsen S.O., et al. Risk of fetal death after pandemic influenza virus infection or vaccination. New Engl J Med 2013, 368(January (4)):333-340.
16. Centers for Disease Control Prevention Influenza vaccination coverage among pregnant women - United States, 2012-13 influenza season. Morb Mortal Wkl Rep 2013, 62(September (38)):787-792.
17. Halperin B.A., MacKinnon-Cameron D., McNeil S., Kalil J., Halperin S.A. Maintaining the momentum: key factors influencing acceptance of influenza vaccination among pregnant women following the H1N1 pandemic. Hum Vaccine Immunother 2014, 10(12):3629-3641.
18. Yudin M.H. Risk management of seasonal influenza during pregnancy: current perspectives. Int J Women Health 2014, 6:681-689.
19. Vitek C.R., Pascual F.B., Baughman A.L., Murphy T.V. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J 2003, 22(July (7)):628-634.
20. Edwards K.M. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 2005, 24(June (Suppl. 6)):S104-S108.
21. Tanaka M.V.C., Pascual F., Bisgard K.M., Tate J.E., Murphy T.V. Trends in pertussis among infants in the United States, 1980-1999. J Am Med Assoc 2003, 290(22):2968-2975.
22. Munoz F.M., Bond N.H., Maccato M., Pinell P., Hammill H.A., Swamy G.K., et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. J Am Med Assoc 2014, 311(May (17)):1760-1769.
23. Pertussis maternal immunization study, https://clinicaltrials.gov/ct2/show/NCT00553228 [accessed 31.07.15].
24. Safety in pregnant women (Tdap), https://clinicaltrials.gov/ct2/show/NCT02209623 [accessed 31.07.15].
25. Centers for Disease Control Prevention Pneumococcal disease 2015, http://www.cdc.gov/pneumococcal/index.html [accessed May 2].
26. Laibl V.R., Sheffield J.S. Influenza and pneumonia in pregnancy. Clin Perinat 2005, 32(September (3)):727-738.
27. Centers for Disease Control Prevention Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). Morbid Mortal Wkl Rep 2010, 59(September (34)):1102-1106.
28. Centers for Disease Control Prevention Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbid Mortal Wkl Rep 2012, 61(October (40)):816-819.
29. Centers for Disease Control Prevention Guidelines for vaccinating pregnant women 2015, http://www.cdc.gov/vaccines/pubs/preg-guide.htm#ppsv23 [accessed May 10].
30. Makris M.C., Polyzos K.A., Mavros M.N., Athanasiou S., Rafailidis P.I., Falagas M.E. Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review. Drug Saf Int J Med Toxicol Drug Exp 2012, 35(January (1)):1-14.
31. Chaithongwongwatthana S., Yamasmit W., Limpongsanurak S., Lumbiganon P., Tolosa J.E. Pneumococcal vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev 2015, 1:CD004903.
32. Cohn A.C., MacNeil J.R., Clark T.A., Ortega-Sanchez I.R., Briere E.Z., Meissner H.C., et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Recomm Rep Morb Mortal Wkl Rep 2013, 62(March (RR-2)):1-28.
33. O'Dempsey T.J., McArdle T., Ceesay S.J., Secka O., Demba E., Banya W.A., et al. Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy. Arch Dis Child Fetal Neonatal Ed 1996, 74(January (1)):F43-F46.
34. Fiore A.E., Wasley A., Bell B.P. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Recomm Rep Morb Mortal Wkl Rep 2006, 55(May (RR-7)):1-23.
35. Centers for Disease Control Prevention Surveillance for viral hepatitis - United States 2013 2015, http://www.cdc.gov/hepatitis/Statistics/2013Surveillance/index.htm [accessed 10.05.15].
36. Mast E.E., Weinbaum C.M., Fiore A.E., Alter M.J., Bell B.P., Finelli L., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. Recomm Rep Morb Mortal Wkl Rep 2006, 55(December (RR-16)):1-33. quiz CE31-34.
37. American College of Obstetricians Gynecologists ACOG practice bulletin no. 86 viral hepatitis in pregnancy. Obstet Gynecol 2007, 110(October (4)):941-956.
38. Centers for Disease Control and Prevention Group B Strep infection in newborns 2015, http://www.cdc.gov/groupbstrep/clinical-overview.html [accessed May 2].
39. Baker C.J., Kasper D.L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. New Engl J Med 1976, 294(April (14)):753-756.
40. Muller A.E., Oostvogel P.M., Steegers E.A., Dorr P.J. Morbidity related to maternal group B streptococcal infections. Acta Obstet Gynecol Scand 2006, 85(9):1027-1037.
41. Hill J.B., Sheffield J.S., McIntire D.D., Wendel G.D. Acute pyelonephritis in pregnancy. Obstet Gynecol 2005, 105(January (1)):18-23.
42. Gibbs R.S., Schrag S., Schuchat A. Perinatal infections due to group B streptococci. Obstet Gynecol 2004, 104(November (5 Pt 1)):1062-1076.
43. Immune response induced by a vaccine against group, B., Streptococcus and safety in pregnant women and their, offsprings., 2015;, https://clinicaltrials.gov/show/NCT01446289. [Accessed 2.05.15].
44. Centers for Disease Control Prevention RSV trends and surveillance 2015, http://www.cdc.gov/rsv/research/us-surveillance.html [accessed 11.05.15].
45. Kim H.W., Canchola J.G., Brandt C.D., Pyles G., Chanock R.M., Jensen K., et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969, 89(April (4)):422-434.
46. Chu H.Y., Steinhoff M.C., Magaret A., et al. Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh. J Infect Dis 2014, 210(November (10)):1582-1589.
47. Falsey A.R., Hennessey P.A., Formica M.A., Cox C., Walsh E.E. Respiratory syncytial virus infection in elderly and high-risk adults. New Engl J Med 2005, 352(April (17)):1749-1759.
48. Wheeler S.M.D.-K.S, Heine R.P., Grotegut C.A., Swamy G.K. The maternal impact of respiratory syncytial virus during pregnancy. Emerg Infect Dis 2015, June, 23. In press, accepted for publication.